(19)
(11) EP 3 198 278 A1

(12)

(43) Date of publication:
02.08.2017 Bulletin 2017/31

(21) Application number: 15844912.4

(22) Date of filing: 24.09.2015
(51) International Patent Classification (IPC): 
G01N 33/574(2006.01)
C12Q 1/68(2006.01)
G01N 33/53(2006.01)
G01N 33/50(2006.01)
(86) International application number:
PCT/US2015/051899
(87) International publication number:
WO 2016/049291 (31.03.2016 Gazette 2016/13)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 25.09.2014 US 201462055491 P

(71) Applicant: Epic Sciences, Inc.
San Diego, CA 92121 (US)

(72) Inventor:
  • DITTAMORE, Ryan
    San Diego, CA 92121 (US)

(74) Representative: Jones Day 
Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11
80538 München
80538 München (DE)

   


(54) CIRCULATING TUMOR CELL DIAGNOSTICS FOR IDENTIFICATION OF RESISTANCE TO ANDROGEN RECEPTOR TARGETED THERAPIES